<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37205321</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2753-6130</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2023</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Global advances in integrative medicine and health</Title><ISOAbbreviation>Glob Adv Integr Med Health</ISOAbbreviation></Journal><ArticleTitle>Pilot Observational Study of Patient Reported Outcome Measures for Long COVID Patients in Virtual Integrative Medical Group Visits.</ArticleTitle><Pagination><StartPage>27536130231174236</StartPage><MedlinePgn>27536130231174236</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">27536130231174236</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/27536130231174236</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Long COVID is a common, debilitating post-infectious illness for which effective management is unknown. Integrative Medical Group Visits (IMGV) are effective interventions for chronic conditions and could benefit Long COVID patients. More information is needed regarding existing patient reported outcome measures (PROMs) to evaluate efficacy of IMGV for Long COVID.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study assessed the feasibility of specific PROMS to evaluate IMGVs for Long COVID. Findings will inform future efficacy trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The Perceived Stress Scale (PSS-10), General Anxiety Disorder two-question tool (GAD-2), Fibromyalgia Symptom Severity scale (SSS), and Measure Yourself Medical Outcome Profile (MYMOP&#xae;) were collected pre- and post-group by teleconferencing platform or telephone and compared using paired t-tests. Patients were recruited from a Long COVID specialty clinic where they participated in 2-hour - 8 weekly IMGV sessions online.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Twenty-seven participants enrolled and completed pre-group surveys. Fourteen participants were reachable by phone post-group and completed all pre and post PROMs (78.6% female, 71.4% non-Hispanic White, mean age 49). MYMOP&#xae; primary symptomatology was fatigue, shortness of breath and "brain fog". Symptoms decreased in interference when compared to pre-group levels (mean difference -1.3 [95% CI-2.2, -.5]). PSS scores decreased (-3.4 [95% CI -5.8, -1.1]), and GAD-2 mean difference was -1.43 (95% CI -3.12, .26). There were no changes in SSS scores of fatigue (-.21 [95% CI -.68,0.25]), waking unrefreshed (.00 [95%CI -.32, -.32]), or trouble thinking (-.21 [95% CI -.78,0.35]).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">All PROMs were feasible to administer via teleconferencing platform or telephone. The PSS, GAD-2 and MYMOP&#xae; are promising PROMs to track Long COVID symptomatology among IMGV participants. The SSS, while feasible to administer, did not change compared to baseline. Larger, controlled studies are needed to determine the efficacy of virtual IMGVs to address the needs of this large and growing population.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barnhill</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0003-3360-4217</Identifier><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation><Identifier Source="RINGGOLD">2332</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roth</LastName><ForeName>Isabel J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation><Identifier Source="RINGGOLD">2332</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Vanessa E</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>Department of Injury Prevention Resource Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation><Identifier Source="RINGGOLD">2332</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baratta</LastName><ForeName>John M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-1124-7928</Identifier><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation><Identifier Source="RINGGOLD">2332</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chilcoat</LastName><ForeName>Aisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation><Identifier Source="RINGGOLD">2332</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavalakatt</LastName><ForeName>Bethany M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation><Identifier Source="RINGGOLD">2332</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiedt</LastName><ForeName>Malik K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation><Identifier Source="RINGGOLD">2332</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Karla L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation><Identifier Source="RINGGOLD">2332</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardiner</LastName><ForeName>Paula</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-3663-000X</Identifier><AffiliationInfo><Affiliation>Center for Mindfulness and Compassion, Cambridge Health Alliance, Cambridge, MA, USA.</Affiliation><Identifier Source="RINGGOLD">2193</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Glob Adv Integr Med Health</MedlineTA><NlmUniqueID>9918556687906676</NlmUniqueID><ISSNLinking>2753-6130</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">group visit</Keyword><Keyword MajorTopicYN="N">integrative</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">telemedicine</Keyword><Keyword MajorTopicYN="N">whole person care</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37205321</ArticleId><ArticleId IdType="pmc">PMC10186579</ArticleId><ArticleId IdType="doi">10.1177/27536130231174236</ArticleId><ArticleId IdType="pii">10.1177_27536130231174236</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, et al.Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 Years &#x2014; United States, March 2020&#x2013;November 2021. MMWR Morb Mortal Wkly Rep. 2022;71(21):713-717. doi:10.15585/MMWR.MM7121E1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/MMWR.MM7121E1</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html Post-COVID Conditions: Information for Healthcare Providers. (n.d.).
Retrieved May 3, 2023, from.</Citation></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al.Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881-895.e20. doi:10.1016/J.CELL.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al.Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al.Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv. 2021;28:21259452. Published online July 3, 2021:2021.06. doi:10.1101/2021.06.28.21259452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera JE, Niehaus WN, Whiteson J, et al.Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PM&amp;R. 2021;13(9):1027-1043. doi:10.1002/pmrj.12684</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12684</ArticleId><ArticleId IdType="pmc">PMC8441628</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine JS, Ambrose AF, Didehbani N, et al.Multi&#x2010;disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2 infection (PASC). PM&amp;R. 2022;14(1):96-111. doi:10.1002/pmrj.12745</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12745</ArticleId><ArticleId IdType="pubmed">34902226</ArticleId></ArticleIdList></Reference><Reference><Citation>Maley JH, Alba GA, Barry JT, et al.Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 2022;14(1):77-95. doi:10.1002/PMRJ.12744</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/PMRJ.12744</ArticleId><ArticleId IdType="pubmed">34902224</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner P, Lestoquoy AS, Gergen-Barnett K, et al.Design of the integrative medical group visits randomized control trial for underserved patients with chronic pain and depression. Contemp Clin Trials. 2017;54:25-35. doi:10.1016/j.cct.2016.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2016.12.013</ArticleId><ArticleId IdType="pubmed">27979754</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner P, Dresner D, Barnett KG, Sadikova E, Saper R. Medical group visits: A feasibility study to manage patients with chronic pain in an underserved urban clinic. Glob Adv Health Med. 2014;3(4):20-26. doi:10.7453/gahmj.2014.011</Citation><ArticleIdList><ArticleId IdType="doi">10.7453/gahmj.2014.011</ArticleId><ArticleId IdType="pmc">PMC4104558</ArticleId><ArticleId IdType="pubmed">25105072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH. Review of the psychometric evidence of the perceived stress scale. Asian Nurs Res. 2012;6(4):121-127. doi:10.1016/J.ANR.2012.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ANR.2012.08.004</ArticleId><ArticleId IdType="pubmed">25031113</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW, Monahan PO, L&#xf6;we B. Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317-325. doi:10.7326/0003-4819-146-5-200703060-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-146-5-200703060-00004</ArticleId><ArticleId IdType="pubmed">17339617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F, Clauw DJ, Fitzcharles MA, et al.The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600-610. doi:10.1002/ACR.20140</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ACR.20140</ArticleId><ArticleId IdType="pubmed">20461783</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson C.Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. BMJ (Clinical Research Ed.) 1996;312(7037):1016-1020. 10.1136/bmj.312.7037.1016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.312.7037.1016</ArticleId><ArticleId IdType="pmc">PMC2350813</ArticleId><ArticleId IdType="pubmed">8616351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishaque S, Johnson JA, Vohra S. Individualized health-related quality of life instrument Measure Yourself Medical Outcome Profile (MYMOP) and its adaptations: A critical appraisal. Qual Life Res. 2019;28(4):879-893. doi:10.1007/S11136-018-2046-6/TABLES/4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11136-018-2046-6/TABLES/4</ArticleId><ArticleId IdType="pubmed">30426277</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F, Ciaffi J, Mancarella L, et al.Fibromyalgia: A new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021;7(3):e001735. doi:10.1136/rmdopen-2021-001735</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2021-001735</ArticleId><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth IJ, Tiedt MK, Barnhill JL, et al.Feasibility of implementation mapping for integrative medical group visits. J Altern Complement Med. 2021;27(S1):S71-S80. doi:10.1089/ACM.2020.0393</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ACM.2020.0393</ArticleId><ArticleId IdType="pmc">PMC8035918</ArticleId><ArticleId IdType="pubmed">33788606</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth I, Kavalakatt B, Chilcoat A, et al.Implementing Integrative Medical Group Visits for Patients with Chronic Pain: Findings from a Pilot Study. APHA.; 2021.</Citation></Reference><Reference><Citation>Gardiner P, Luo M, D&#x2019;Amico S, et al.Effectiveness of integrative medicine group visits in chronic pain and depressive symptoms: A randomized controlled trial. PLoS One. 2019;14(12):e0225540. doi:10.1371/journal.pone.0225540</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0225540</ArticleId><ArticleId IdType="pmc">PMC6919581</ArticleId><ArticleId IdType="pubmed">31851666</ArticleId></ArticleIdList></Reference><Reference><Citation>https://support.sas.com/software/94/ SAS 9.4 Software Overview for the Customer. (n.d.). Retrieved May 3,
2023, from.</Citation></Reference><Reference><Citation>Hussain-Shamsy N, McMillan I, Cook S, et al.Operationalizing and evaluating synchronous virtual group health interventions: Wide-scale implementation at a tertiary care academic hospital. J Med Internet Res. 2022;24(4):e29841. doi:10.2196/29841</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/29841</ArticleId><ArticleId IdType="pmc">PMC9030913</ArticleId><ArticleId IdType="pubmed">35389350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Saper R, Patil SJ. Long COVID shared medical appointments: Lifestyle and mind-body medicine with peer support. Ann Fam Med. 2022;20:383. Published online April 20. doi:10.1370/afm.2817</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.2817</ArticleId><ArticleId IdType="pmc">PMC9328700</ArticleId><ArticleId IdType="pubmed">35443975</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner P, Lestoquoy AS, Negash NL, et al.Lessons learned and strategies for recruitment of diverse, low-income patients into an integrative medical group visit clinical trial. Explore. 2019;15(3):215-221. doi:10.1016/j.explore.2019.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.explore.2019.01.003</ArticleId><ArticleId IdType="pubmed">31056423</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938. doi:10.1136/BMJ.M4938</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.M4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>